Quantcast
slattery_t_web

Timothy Slattery

Associate

Timothy Slattery is an associate in the Antitrust Group of the Washington, DC office.

Selected Publications

  • “Takeaways from 2nd Circ.’s Apple E-Books Ruling”, co-authored, Law360 (July 2015)
  • “11th Circ. Exclusive Dealing Decision Big Win for FTC”, co-authored, Law360 (April 2015)
  • “What Pom Wonderful v. FTC Means for Class Actions”, co-authored, Law360 (February 2015)
  • “An Early Test of Antitrust Ramifications of FDA’s REMS”, co-authored, Law360 (January 2015)
  • “Medtronic Deal Highlights FTC Focus On Future Competition”, co-authored, Law360 (January 2015)
  • “Milk Processors Soured After Rare Monopsony Ruling”, Law360 (June 2014)
  • “FTC Check-Up on Health Care Trends Reveals New Competitive Wrinkles—Highlights from the FTC Workshop Examining Health Care Competition”, co-authored, Health Lawyers Weekly (April 2014)
  • Note, “The Dormant Commerce Clause: Adopting a New Standard and a Return to Principle”, 17 Wm. & Mary Bill Rts. J. 1243 (2009)
Loading...
Loading...

Education

  • William & Mary School of Law, J.D.
    • Senior Notes Editor, Bill of Rights Journal
  • College of William and Mary, BS, Economics & BBA, Finance, summa cum laude, Phi Beta Kappa

Admissions/Qualifications

Languages

Connect With Us